Center for the Study of Hepatitis C, Laboratory of Virology and Infectious Diseases, The Rockefeller University, New York, NY 10021, USA.
Hepatology. 2011 Dec;54(6):1901-12. doi: 10.1002/hep.24557.
Here we demonstrate that primary cultures of human fetal liver cells (HFLC) reliably support infection with laboratory strains of hepatitis C virus (HCV), although levels of virus replication vary significantly between different donor cell preparations and frequently decline in a manner suggestive of active viral clearance. To investigate possible contributions of the interferon (IFN) system to control HCV infection in HFLC, we exploited the well-characterized ability of paramyxovirus (PMV) V proteins to counteract both IFN induction and antiviral signaling. The V proteins of measles virus (MV) and parainfluenza virus 5 (PIV5) were introduced into HFLC using lentiviral vectors encoding a fluorescent reporter for visualization of HCV-infected cells. V protein-transduced HFLC supported enhanced (10 to 100-fold) levels of HCV infection relative to untransduced or control vector-transduced HFLC. Infection was assessed by measurement of virus-driven luciferase, by assays for infectious HCV and viral RNA, and by direct visualization of HCV-infected hepatocytes. Live cell imaging between 48 and 119 hours postinfection demonstrated little or no spread of infection in the absence of PMV V protein expression. In contrast, V protein-transduced HFLC showed numerous HCV infection events. V protein expression efficiently antagonized the HCV-inhibitory effects of added IFNs in HFLC. In addition, induction of the type III IFN, IL29, following acute HCV infection was inhibited in V protein-transduced cultures.
These studies suggest that the cellular IFN response plays a significant role in limiting the spread of HCV infection in primary hepatocyte cultures. Strategies aimed at dampening this response may be key to further development of robust HCV culture systems, enabling studies of virus pathogenicity and the mechanisms by which HCV spreads in its natural host cell population.
在这里,我们证明人胎肝细胞(HFLC)的原代培养物可靠地支持实验室株丙型肝炎病毒(HCV)的感染,尽管不同供体细胞制备物之间的病毒复制水平差异很大,并且经常以提示病毒主动清除的方式下降。为了研究干扰素(IFN)系统对控制 HFLC 中 HCV 感染的可能贡献,我们利用副粘病毒(PMV)V 蛋白对抗 IFN 诱导和抗病毒信号的能力。使用编码用于可视化 HCV 感染细胞的荧光报告基因的慢病毒载体将麻疹病毒(MV)和副流感病毒 5(PIV5)的 V 蛋白引入 HFLC。与未转导或对照载体转导的 HFLC 相比,V 蛋白转导的 HFLC 支持 HCV 感染水平增强(10 至 100 倍)。通过测量病毒驱动的荧光素酶、检测感染性 HCV 和病毒 RNA 的测定以及直接观察 HCV 感染的肝细胞来评估感染。在感染后 48 至 119 小时之间进行的活细胞成像显示,在没有 PMV V 蛋白表达的情况下,感染的传播很少或没有。相比之下,V 蛋白转导的 HFLC 显示出许多 HCV 感染事件。V 蛋白表达有效地拮抗了 HFLC 中添加 IFN 对 HCV 的抑制作用。此外,在 V 蛋白转导的培养物中,急性 HCV 感染后诱导的 III 型 IFN,IL29,受到抑制。
这些研究表明,细胞 IFN 反应在限制 HCV 感染在原代肝细胞培养物中的传播中起重要作用。抑制这种反应的策略可能是进一步开发强大的 HCV 培养系统的关键,使研究病毒的致病性和 HCV 在其自然宿主细胞群中传播的机制成为可能。